Tokyo, Nov. 14 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059765) titled 'Burden of disease study in migraine patients in Japan' on Nov. 13.
Study Type:
Observational
Primary Sponsor:
Institute - AbbVie GK
Condition:
Condition - Migraine
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To describe the disease burden in Japanese migraine patients who present to the medical facility that meets the requirements specified in the Optimal Clinical Use Guidelines (OUG) for the use of anti-Calcitonin Gene-Related Peptide (CGRP) antibodies (OUG facility) or Non-OUG facility
Basic objectives2 - Others
Eligibility:
Age-lower limit - 15
years-old
<...